Pharvaris (PHVS) Shares Outstanding (2020 - 2025)
Pharvaris (PHVS) reported Shares Outstanding of $75.9 million for Q4 2025, up 30.63% on a YoY basis from $58.1 million in Q4 2024, and up 30.63% quarter-over-quarter from $58.1 million in Q4 2024.
Pharvaris (PHVS) Shares Outstanding (2020 - 2025) Analysis & Trends
Pharvaris has reported Shares Outstanding for 6 years, with the latest figure at $75.9 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding rose 30.63% year-over-year to $75.9 million; the trailing twelve-month figure through Dec 2025 stood at $75.9 million (up 30.63% YoY), and the FY2025 full-year result was $73.7 million, up 25.18% from the prior year.
- Shares Outstanding for Q4 2025 stood at $75.9 million, up from $58.1 million in the prior quarter.
- The five-year high for Shares Outstanding was $75.9 million in Q4 2025, with the low at $34.5 million in Q4 2022.
- Historically, Shares Outstanding has averaged $52.5 million across 5 years, with a median of $56.3 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding soared 555.84% — and 2022, when it slipped 9.03%.
- Pharvaris' Shares Outstanding stood at $37.9 million in 2021, then decreased by 9.03% to $34.5 million in 2022, then surged by 63.07% to $56.3 million in 2023, then advanced by 3.29% to $58.1 million in 2024, then surged by 30.63% to $75.9 million in 2025.
- The last three Shares Outstanding figures came in at $75.9 million (Q4 2025), $58.1 million (Q4 2024), and $56.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |